A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...

WEDNESDAY, Nov. 12, 2024 (HealthDay News) -- Overtreatment of prostate cancer is increasing in the United States among men with limited life expectancy, a new study reports. Procedures like radiation ...

Mr. Green, a 50-something businessman was asking a question I find myself answering on a surprisingly regular basis: “So, my ...

A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of ...

Hormone therapy is commonly combined with radiation therapy for prostate cancer, but patients are often unsure how long it should be continued and why. A new study published in JAMA Oncology from ...

A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...

Men diagnosed with nonmetastatic low- and intermediate-risk prostate cancer up to 6 times more likely to die of other causes. HealthDay News — Men with nonmetastatic prostate cancer receiving ...

Treatment with Leuprorelin did not improve OS or disease-specific survival for patients with nonmetastatic, high-risk prostate cancer who have undetectable PSA levels, while causing more adverse ...

A study from HKUMed demonstrates that prostate-specific antigen (PSA) screening can significantly reduce the incidence of ...

Consider this a PSA about PSA. Prostate cancer is the most common cancer in US men, excluding skin cancer, and the second-leading cause of male cancer deaths, after lung cancer. One in 6 men will be ...

CLEVELAND – Hormone therapy is commonly combined with radiation therapy for prostate cancer, but patients are often unsure how long it should be ...